Samuli Ojala, Vaasan Hietalahden Apteekki
Discover the importance of personalized medicine through compounding and how it benefits niche patient groups like pets, children, and the elderly.
Interview with Erik Haeffler, CEO, APL
Interview with Erik Haeffler on APL's role in developing personalized medicines for patients with unique needs using innovative CSS-technology.